News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,214 Results
Type
Article (88685)
Company Profile (816)
Press Release (792684)
Multimedia
Podcasts (233)
Webinars (35)
Section
Business (233551)
Career Advice (4160)
Deals (39966)
Drug Delivery (175)
Drug Development (91660)
Employer Resources (207)
FDA (18542)
Job Trends (17477)
News (398634)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3049)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (187)
Alliances (56988)
ALS (228)
Alzheimer's disease (1954)
Antibody-drug conjugate (ADC) (525)
Approvals (18856)
Artificial intelligence (841)
Autoimmune disease (339)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (209)
Brain cancer (83)
Breast cancer (816)
Cancer (6339)
Cardiovascular disease (544)
Career advice (3594)
Career pathing (51)
CAR-T (369)
CDC (76)
Celiac Disease (3)
Cell therapy (1038)
Cervical cancer (51)
Clinical research (78670)
Collaboration (2304)
Company closure (8)
Compensation (1461)
Complete response letters (103)
COVID-19 (3036)
CRISPR (120)
C-suite (1240)
Cystic fibrosis (166)
Data (8340)
Decentralized trials (3)
Denatured (88)
Depression (189)
Dermatology (94)
Diabetes (647)
Diagnostics (7547)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (412)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (310)
Earnings (102453)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138076)
Executive appointments (1173)
FDA (22499)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1885)
Gene editing (266)
Generative AI (87)
Gene therapy (840)
GLP-1 (1257)
Government (5551)
Grass and pollen (8)
Guidances (415)
Healthcare (21168)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (351)
Immuno-oncology (107)
Indications (197)
Infectious disease (3422)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (308)
Interviews (820)
IPO (17995)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (115)
Layoffs (682)
Leadership (52)
Legal (10171)
Liver cancer (109)
Longevity (36)
Lung cancer (833)
Lymphoma (445)
Machine learning (65)
Management (66)
Manufacturing (1181)
MASH (219)
Medical device (15251)
Medtech (15389)
Mergers & acquisitions (23249)
Metabolic disorders (1733)
mRNA (258)
Multiple sclerosis (201)
NASH (24)
Neurodegenerative disease (487)
Neuropsychiatric disorders (125)
Neuroscience (3640)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5139)
Now hiring (79)
Obesity (832)
Opinion (370)
Ovarian cancer (237)
Pain (281)
Pancreatic cancer (326)
Parkinson's disease (402)
Partnered (39)
Patents (637)
Patient recruitment (721)
Peanut (67)
People (67857)
Pharmaceutical (136)
Pharmacy benefit managers (36)
Phase 1 (24311)
Phase 2 (34175)
Phase 3 (25689)
Pipeline (9279)
Policy (393)
Postmarket research (3559)
Preclinical (10947)
Press Release (72)
Prostate cancer (330)
Psychedelics (68)
Radiopharmaceuticals (362)
Rare diseases (1223)
Real estate (7461)
Recruiting (81)
Regulatory (30216)
Reports (78)
Research institute (2765)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (317)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1288)
Venture capital (127)
Weight loss (573)
Women's health (136)
Worklife (24)
Date
Today (202)
Last 7 days (642)
Last 30 days (3733)
Last 365 days (33119)
2026 (14570)
2025 (33225)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (394)
Arkansas (16)
Asia (52170)
Australia (9176)
California (14060)
Canada (3942)
China (1494)
Colorado (603)
Connecticut (620)
Delaware (432)
Europe (120313)
Florida (2080)
Georgia (460)
Hawaii (4)
Idaho (69)
Illinois (1195)
India (100)
Indiana (651)
Iowa (25)
Japan (569)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1709)
Massachusetts (10260)
Michigan (421)
Minnesota (782)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3726)
New Mexico (34)
New York (3682)
North Carolina (1902)
North Dakota (11)
Northern California (6966)
Ohio (437)
Oklahoma (26)
Oregon (55)
Pennsylvania (2787)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5504)
Tennessee (223)
Texas (2280)
United States (50284)
Utah (421)
Vermont (1)
Virginia (357)
Washington D.C. (88)
Washington State (1157)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,214 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
May 27, 2026
·
12 min read
Press Releases
Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026
·
2 min read
Press Releases
Zealand Pharma to participate in the Jefferies Global Healthcare Conference 2026
May 27, 2026
·
1 min read
Press Releases
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
·
9 min read
Press Releases
Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline
May 27, 2026
·
3 min read
Press Releases
Therini Bio Doses First Patients in Phase 1b Trial of Novel Anti-Inflammatory Therapy, THN391, for Diabetic Macular Edema
May 27, 2026
·
3 min read
Rare diseases
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
The FDA’s priority review acceptance of BridgeBio’s BBP-418 is another step toward what William Blair previously dubbed a “diversified commercial portfolio.” It also adds to the rapidly building momentum in muscular dystrophy more broadly.
May 27, 2026
·
3 min read
·
Heather McKenzie
Immunology and inflammation
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss
Apogee’s pipeline in a product drug zumilokibart achieved significant disease clearance in a mid-stage atopic dermatitis trial, but investors were miffed by a royalty financing deal with Blackstone.
May 27, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Wolters Kluwer and Radiological Society of North America Establish 10-Year Agreement to Advance Global Access to Leading Radiology Research Journals
May 27, 2026
·
3 min read
Press Releases
Forlong Announces Completion of Phase I Clinical Studies of FL115 Monotherapy (IV): Disease Control for 3 Heavily-pretreated Patients with Advanced Solid Tumors over 12 Months
May 27, 2026
·
4 min read
1 of 88,222
Next
